Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioTrove Announces Issuance of First Patent for the Living Chip Massively Parallel Drug Discovery Technology.


Business Editors and Health/Medical Writers

CAMBRIDGE, Mass.--(BW HealthWire)--June 3, 2002

BioTrove announced today that MIT MIT - Massachusetts Institute of Technology  has received a patent on the Living Chip(TM) technology, which is licensed exclusively world-wide to BioTrove.

U.S. patent No. 6,387,331 has been issued to the Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, , where the basic technology was invented. The patent encompasses the microchips as well as the imaging system used with the chips.

BioTrove has developed the Living Chip(TM) technology as a biotechnology platform for Massively Parallel See MPP.  Screening, Storage and Synthesis.

"The Living Chip(TM) is a total solution for nano-volume super-high-throughput chemical or biological library management and screening," stated Tom Morrison Tom Morrison (or similar) is the name of several persons:
  • Tom Morrison (footballer) (born 1904), Scottish footballer
  • Tommy Morrison (born 1969), Irish-American boxer
  • Thomas Morrison (actor), UK television actor (starred in Blackpool)
, Director of Biomolecular Discovery. "The platform will make compound and biological libraries immediately and directly accessible to scientists with a minimum footprint in terms of storage and associated instrumentation. Other benefits to the end-user include 100-fold reduction in sample volumes and a throughput in the millions of assays per day with a high degree of assay flexibility."

The Living Chip(TM) consists of a precisely constructed, high-density arrays of micro-channels, or bottomless bot·tom·less  
adj.
1. Having no bottom.

2. Too deep to be measured: a bottomless glacier lake.

3.
 wells, in a plate. The Living Chip(TM) may be thought of as a dense array of test-tubes that are easily filled and washed. The system combines the advantages of high-density arrays on glass slides, with the added functionality that liquids and gases may easily pass into and out of the channels.

About BioTrove:

BioTrove Inc. is a privately held, biotechnology company focused on leveraging revolutionary micro- and nano-scale engineering solutions to overcome current bottlenecks in drug discovery and biotechnology. BioTrove has two core technology platforms: the Living Chip(TM)and the Lab-on-a-Tape(TM).

The BioTrove team integrates biologists, analytical chemists and material scientists with electro-mechanical, optical, chemical and software engineers creating a cohesive cohesive,
n the capability to cohere or stick together to form a mass.
 interdisciplinary approach to technology development. BioTrove offers both library storage and screening services based on the core technology to partners. BioTrove's goal is to provide a solution to store and analyze at rates approaching one billion samples per day in nanoliter volumes.

The Living Chip technology was invented at MIT by Professor Ian Hunter Ian Hunter is the name of:
  • Ian Hunter (actor), a British character actor
  • Ian Hunter (cricketer), a cricketer with Derbyshire County Cricket Club
  • Ian Hunter (impresario) (1919-2003), British classical music impresario
 of Mechanical Engineering and the Division of Bioengineering bioengineering

Application of engineering principles and equipment to biology and medicine. It includes the development and fabrication of life-support systems for underwater and space exploration, devices for medical treatment (see
 and Environmental Health. He is a co-founder of BioTrove.

For more information visit BioTrove's website at http://www.biotrove.com.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:BioTrove Announces Issuance of First Patent for the Living Chip Massively Parallel Drug Discovery Technology.
Publication:Business Wire
Geographic Code:1USA
Date:Jun 3, 2002
Words:380
Previous Article:RADVISION Announces New SIP Server Toolkit for Developing Enhanced Server Applications.
Next Article:KANA's Web-Architected eCRM Solutions Heighten Customer Service in the Telecommunications Industry.



Related Articles
AIDS and Developing Countries: Democratizing Access to Essential Medicines.
Facilitating Access to Essential Medicines.
Toward a New Foreign Policy.
BioTrove Announces Advanced Technology Program Award from N.I.S.T. for Massively Parallel Screening.
BioTrove Announces Completion of One Million Cell Assays With the Living Chip Technology.
454 LIFE SCIENCES GETS GENOME LICENSE FROM PYROSEQUENCING.
BioTrove, Inc. Purchases Through Hole Array Intellectual Property Portfolio from Genencor International Inc.
BioTrove, Inc. Names Robert H. Ellis as President and Chief Executive Officer.
BioTrove, Inc. Secures $10.9 Million to Continue the Development and Commercialization of Novel Nano-Scale Drug Discovery Solutions.
BioTrove, Inc. Appoints Patrick Carroll as Chief Business Officer.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles